Quadria Capital plans to invest about half its capital in Indian entities that offer healthcare solutions to address adverse situations brought about by climate change, a senior executive said. “These are all models catering to the challenges, both in terms of mitigating as well as adapting to climate change," Thakur said, without identifying any potential companies shortlisted for investment. “The …
Singapore- and New Delhi-based private equity firm Quadria Capital has marked the first close of its third investment vehicle. "The first close of our third fund serves as a clear validation of investors’ confidence in our strategy and consistent execution," said Abrar Mir, co-founder and managing partner of Quadria Capital, in a statement. While Quadria did not name the limited …
Quadria Capital, a healthcare-focused investor, has started distributing the gains from its 10-year-old first fund, along with the principal, to its limited partners or investors. And currently, the fund is tracking in NAV closer to 2.9x cash-on-cash," Amit Varma, managing partner, Quadria Capital, said in an interview. Quadria Capital’s inaugural fund’s target corpus was $300 million, although it eventually invested …
Concord Biotech IPO Listing: Concord Biotech made a stellar debut on the stock exchanges Friday. The shares of Concord Biotech were listed with a premium of 21.46% at ₹900.05 apiece on the BSE, as compared to the issue price of Rs 741 per share. Concord Biotech IPO had received strong interest from investors as the public issue was subscribed by …
